Pearl River Capital, LLC Veracyte, Inc. Transaction History

Pearl River Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$36.09 - $53.79 $252,738 - $376,691	-7,003 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$35.62 - $52.97 $262,839 - $390,865	-7,379 Reduced 51.31%	7,003 $325,000
Q2 2021 Aug 13, 2021	BUY	$32.94 - $56.62 $331,541 - $569,880	10,065 Added 233.15%	14,382 $575,000
Q1 2021 May 14, 2021	SELL	$44.47 - $81.38 $48,605 - $88,948	-1,093 Reduced 20.2%	4,317 $232,000
Q4 2020 Feb 12, 2021	BUY	$32.49 - $61.88 $175,770 - $334,770	5,410 New	5,410 $265,000

257

81.7M

43K

82K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $1.54B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.